# OnCo record paper-da-epoch-r-myc-rearranged-lymphoma-lancet-haematol-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-da-epoch-r-myc-rearranged-lymphoma-lancet-haematol-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-da-epoch-r-myc-rearranged-lymphoma-lancet-haematol-2018" ;
  schema:name "Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study"@en ;
  schema:alternateName "Dunleavy 2018"@en ;
  schema:description "In a single-arm study of 53 people with MYC-rearranged aggressive B-cell lymphoma, including double-hit disease, intensive infusional chemotherapy left 71 per cent alive and free of events at four years."@en ;
  schema:url <https://onco.cc/key-papers/paper-da-epoch-r-myc-rearranged-lymphoma-lancet-haematol-2018/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S2352-3026(18)30177-7>, <https://pubmed.ncbi.nlm.nih.gov/30501868/>, <https://europepmc.org/article/MED/30501868> ;
  onco:tag "lymphoma-evidence-entities" ;
  schema:sameAs <https://doi.org/10.1016/S2352-3026(18)30177-7> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Dunleavy K, Fanale MA, Abramson JS, et al." ;
  onco:cancers <https://onco.cc/cancers/high-grade-b-cell-lymphoma-myc-bcl2/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:targets <https://onco.cc/targets/myc-gene/>, <https://onco.cc/targets/bcl2/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/> ;
  onco:terms <https://onco.cc/terms/double-hit-lymphoma/> ;
  onco:trials <https://onco.cc/trials/nci-da-epoch-r-myc-burkitt/>, <https://onco.cc/trials/calgb-50303/> .